Ed Donaldson

Ed Donaldson has a diverse work experience spanning over several years. Ed is currently working as the Director of Sales at MedGenome since 2021. Prior to this, Ed worked as a Business Development Consultant for their own company, providing consultation to small and mid-size businesses on process improvement and actionable planning.

Before that, they held the position of Director of Business Development at Q2 Solutions, where they managed territory sales through new business development. Ed also worked as an Independent Sales Consultant, specializing in life science vertical sales and serving clients such as DSG Inc., EXTEDO, Cytel, and Clinovo.

Earlier in their career, Ed served as the Director of Business Development at DSG Inc., where they independently led new business efforts for the eCaseLink Electronic Data Capture Management Platform. Ed also worked as a Business Development Executive at Research Point and Kendle International, responsible for phase I-IV CRO sales in the West Coast region.

Ed has also gained experience in the financial services sector as the Executive Director/Owner of CU Lending, where they co-founded the company and managed a sales team. Additionally, they worked as an Account Executive at Washington Mutual, identifying and managing new business accounts in the mortgage industry.

Furthermore, Ed has experience in biotech sales, having worked at Pierce Biotechnology. In this role, they utilized consultative sales techniques and territory management skills to grow the company's life science product business.

Overall, Ed Donaldson's work experience showcases their expertise in sales, business development, and consultation across various industries.

Ed Donaldson obtained their Bachelor's Degree in Biochemistry and Molecular Cell Biology from Penn State University, where they attended from 1992 to 1996. In 2001, they briefly studied Statistics at the University of California, Berkeley, although it is not specified whether they completed a degree in this field.